Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

IBN SINA Pharmaceutical Industry Ltd (TISN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
256.60 +3.10    +1.22%
30/04 - Closed. Currency in BDT ( Disclaimer )
Type:  Equity
Market:  Bangladesh
ISIN:  BD0464IBNSN2 
S/N:  IBNSINA
  • Volume: 6,100
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 248.00 - 257.90
IBN SINA Pharma 256.60 +3.10 +1.22%

IBN SINA Pharmaceutical Industry Ltd Company Profile

 
Get an in-depth profile of IBN SINA Pharmaceutical Industry Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

4000

Equity Type

ORD

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflammatory, anti-allergic-occular, anti-arthritis supplement, anti-asthmatic, anti-emetic, anti-fibrinolytic, anti-fungal, anti-glucoma, anti-histamine, anti-malarial, anti-melasma, anti-neuropathic, anti-protozoal, anti-spasmodic, anti-ulcerant, antibacterial, antibiotic, anticataract, anti-diabetic, antigout, anti-helmintic, antimigraine agent, antisecretory, antivertigo agent, and antiviral products. In addition, the company’s therapeutic products comprise antibiotic and steroid, antibiotic-occular, antifungal-occular, antiviral-occular, anxiolytic and antidepressant, aromatase inhibitor, bile acid, bisphosphonates, calcium supplement, cardiovascular preparation, cholinesterase inhibitor, corticosteroid, cough expectorant, dry eye syndrome, gastroprokinetic agent, haematinic/vitamin and mineral, hand rub, hormone products, intestinal anti-inflammatory, laxative, multivitamin and multi-minerals, muscle relaxant, mydriatic agents, nasal decongestant, neuroleptic, nootropic, NSAIDS, NSAIDS-occular, ORS, steroid-occular, topical, urinary incontinence, and sodium-glucose co-transporter inhibitor products. Further, it provides herbal and Unani products; and manufactures and trades in active pharmaceutical ingredients, natural medicines, polymer plastic bottles, plastic tubes, laminated tubes, and other related products. The IBN SINA Pharmaceutical Industry PLC was incorporated in 1983 and is headquartered in Dhaka, Bangladesh.

Contact Information

Address Tanin Center 3 Asad Gate
Mirpur Road Mohammadpur Dhaka, 1207
Bangladesh
Phone 880 2 4102 2148
Fax 880 2 4102 2140

Top Executives

Name Age Since Title
Shah Abdul Hannan 82 1983 Chairman
A. K. M. Sadrul Islam 66 2003 MD & Director
M. A. Rahman 95 1983 Director
Choudhury Mahmood Hasan 68 2013 Technical Director, Finance Director & Director
Abu Nasser Muhammad Abduz Zaher 73 1983 Director
Md. Abdus Salam - - Independent Director
Zehad Khan - 2021 Director
Mohammad Ayub Miah - 2021 Director
Kazi Harun-Or-Rashid 71 2016 Chairman
Abdus Sadeque Bhuiyan 63 2022 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TISN Comments

Write your thoughts about IBN SINA Pharmaceutical Industry Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
SHOFIQ JOARDAR এ
SHOFIQ JOARDAR এ Sep 30, 2021 7:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It is a Very storage Share,
Masud Ahmed
Masud Ahmed Aug 29, 2020 4:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
very good EPS, low paid up capital, very safe investment.
Masud Ahmed
Masud Ahmed Aug 29, 2020 4:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Low paid up capital, very good EPS.
Masud Ahmed
Masud Ahmed Aug 29, 2020 4:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Low paid up capital, very good EPS.
Masud Ahmed
Masud Ahmed Aug 29, 2020 4:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Low paid up capital, very good EPS.
Mohammad Saiful Islam
Mohammad Saiful Islam Jul 14, 2020 2:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
investing here will be safe for enjoying dividend,
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email